We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

ReNeuron Signs Manufacturing Contract to Provide Stem Cells for Stroke Clinical Trial

News   Jun 09, 2009

 
ReNeuron Signs Manufacturing Contract to Provide Stem Cells for Stroke Clinical Trial
 
 
 

RELATED ARTICLES

Switching Embryonic Stem Cells to Neurons to Expose Drug Effects on the Developing Brain

News

A new experimental system has been designed that can rapidly assess the pathogenic effects of a drug on a baby's developing brain. The system uses embryonic stem cells reprogrammed into neurons, and offers a powerful tool for probing genetic and molecular underpinnings of drug-induced neurodevelopmental disorders.

READ MORE

Sickle Cell Drug IMR-687 Shows Promise in Clinical Trial

News

An investigational drug for the treatment of sickle cell disease shows early promise in Phase 2a clinical trial. The orally administered drug, given to adult patients with sickle cell disease, is demonstrating tolerability and the ability to impact both red and white blood cell biomarkers of the disease.

READ MORE

Size Matters for Genome Awakening in Embryos

News

Activation of an embryo's genome does not happen all at once; instead it follows a specific pattern controlled primarily by the various sizes of its cells.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE